.jpg)




JunPyo Han , Yujin Jang
, Dong Yeop Shin
et al.
J Cancer Prev 2022; 27(4): 199-207
https://doi.org/10.15430/JCP.2022.27.4.199Nur Mahirah Amani Binti Mohammad , Mohd Razif Shahril
, Suzana Shahar
et al.
J Cancer Prev 2022; 27(4): 208-220
https://doi.org/10.15430/JCP.2022.27.4.208Soojung Jin , Jung-ha Park
, Hee Jung Yun
et al.
J Cancer Prev 2022; 27(4): 221-228
https://doi.org/10.15430/JCP.2022.27.4.221Mizuho Nakayama , Dong Wang
, Sau Yee Kok
et al.
J Cancer Prev 2022; 27(1): 1-6
https://doi.org/10.15430/JCP.2022.27.1.1Achanta Sri Venakata Jagadeesh , Xizhu Fang
, Seong Hoon Kim
et al.
J Cancer Prev 2022; 27(1): 7-15
https://doi.org/10.15430/JCP.2022.27.1.7Athena Dong , Chien-Wei Lin
, Carla Elena Echeveste
et al.
J Cancer Prev 2022; 27(1): 50-57
https://doi.org/10.15430/JCP.2022.27.1.50Jinyoung Suh , Do-Hee Kim
, Su-Jung Kim
et al.
J Cancer Prev 2022; 27(1): 68-76
https://doi.org/10.15430/JCP.2022.27.1.68Mizuho Nakayama , Dong Wang
, Sau Yee Kok
et al.
J Cancer Prev 2022; 27(1): 1-6
https://doi.org/10.15430/JCP.2022.27.1.1Athena Dong , Chien-Wei Lin
, Carla Elena Echeveste
et al.
J Cancer Prev 2022; 27(1): 50-57
https://doi.org/10.15430/JCP.2022.27.1.50Rakhi Issrani , Jagat Reddy
, Tarek H. El-Metwally Dabah
et al.
J Cancer Prev 2022; 27(1): 16-21
https://doi.org/10.15430/JCP.2022.27.1.16Jinyoung Suh , Do-Hee Kim
, Su-Jung Kim
et al.
J Cancer Prev 2022; 27(1): 68-76
https://doi.org/10.15430/JCP.2022.27.1.68The aim of the journal is to promote an increased awareness of all aspects that ultimately lead to cancer prevention. The journal publishes important original research articles, reviews, editorials, short communications, and letters to the editor with the multi-disciplinary perspectives in the areas of carcinogenesis, chemoprevention, molecular epidemiology, and cancer biology. The journal comprises basic, clinical, and translational research with special attention given to molecular and cellular mechanisms of cancer chemopreventive agents as well as identification of novel risk factors and biomarkers of cancer.
+82-2-888-9122